{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:31:56Z","timestamp":1771954316564,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T00:00:00Z","timestamp":1510099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T00:00:00Z","timestamp":1510099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1111\/jcpt.12649","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T04:16:41Z","timestamp":1510201001000},"page":"1-7","source":"Crossref","is-referenced-by-count":28,"title":["Effects of dopamine receptor antagonist antipsychotic therapy on blood pressure"],"prefix":"10.1155","volume":"43","author":[{"given":"N. H.","family":"Gonsai","sequence":"first","affiliation":[{"name":"Nova Southeastern University College of Pharmacy; Fort Lauderdale FL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. H.","family":"Amin","sequence":"additional","affiliation":[{"name":"Nova Southeastern University College of Pharmacy; Fort Lauderdale FL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. G.","family":"Mendpara","sequence":"additional","affiliation":[{"name":"Nova Southeastern University College of Pharmacy; Fort Lauderdale FL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Speth","sequence":"additional","affiliation":[{"name":"Nova Southeastern University College of Pharmacy; Fort Lauderdale FL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2161-1543","authenticated-orcid":false,"given":"G. M.","family":"Hale","sequence":"additional","affiliation":[{"name":"Nova Southeastern University College of Pharmacy; Fort Lauderdale FL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,11,8]]},"reference":[{"key":"10.1111\/jcpt.12649-BIB0001|jcpt12649-cit-0001","unstructured":"American Heart Association Heart Disease and Stroke Statistics 2016 www.heart.org\/HEARTORG\/General\/Heart-and-Stroke-Association-Statistics_UCM_319064_SubHomePage.jsp"},{"key":"10.1111\/jcpt.12649-BIB0002|jcpt12649-cit-0002","unstructured":"Center for Disease Control and Prevention Health, United States, 2015 www.cdc.gov\/nchs\/data\/hus\/hus15.pdf"},{"key":"10.1111\/jcpt.12649-BIB0003|jcpt12649-cit-0003","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000000065","article-title":"Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension","volume":"32","author":"Weber","year":"2014","journal-title":"J Clin Hypertens"},{"key":"10.1111\/jcpt.12649-BIB0004|jcpt12649-cit-0004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00041552-200201000-00013","article-title":"Role of dopamine receptors in the kidney in the regulation of blood pressure","volume":"11","author":"Jose","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/jcpt.12649-BIB0005|jcpt12649-cit-0005","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.bbadis.2010.02.004","article-title":"Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation","volume":"1802","author":"Jose","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/jcpt.12649-BIB0006|jcpt12649-cit-0006","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/HYPERTENSIONAHA.113.01094","article-title":"Gastrin and D1 dopamine receptor interact to induce natriuresis and diuresis","volume":"62","author":"Chen","year":"2013","journal-title":"Hypertension"},{"key":"10.1111\/jcpt.12649-BIB0007|jcpt12649-cit-0007","doi-asserted-by":"crossref","first-page":"e0146641","DOI":"10.1371\/journal.pone.0146641","article-title":"The synergistic roles of cholecystokinin B and dopamine D5 receptors on the regulation of renal sodium excretion","volume":"11","author":"Jiang","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1111\/jcpt.12649-BIB0008|jcpt12649-cit-0008","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0031-6997(24)01483-2","article-title":"Anti-psychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects","volume":"53","author":"Strange","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1111\/jcpt.12649-BIB0009|jcpt12649-cit-0009","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/FBP.0b013e3282f14ee6","article-title":"Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in rats","volume":"18","author":"Desai","year":"2007","journal-title":"Behav Pharmacol"},{"key":"10.1111\/jcpt.12649-BIB0010|jcpt12649-cit-0010","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/sj.npp.1301305","article-title":"Dopamine and serotonin receptor binding and antipsychotic efficacy","volume":"32","author":"Richtand","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/jcpt.12649-BIB0011|jcpt12649-cit-0011","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/cphy.c130040","article-title":"Classical renin-angiotensin system in kidney physiology","volume":"4","author":"Sparks","year":"2014","journal-title":"Compr Physiol"},{"key":"10.1111\/jcpt.12649-BIB0012|jcpt12649-cit-0012","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1365-201X.1997.00166.x","article-title":"The natriuretic response to a dopamine DA1 agonist requires endogenous activation of dopamine DA2 receptors","volume":"160","author":"Eklof","year":"1997","journal-title":"Acta Physiol Scand"},{"key":"10.1111\/jcpt.12649-BIB0013|jcpt12649-cit-0013","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/HYPERTENSIONAHA.114.04038","article-title":"Activation of D4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells","volume":"65","author":"Chen","year":"2015","journal-title":"Hypertension"},{"key":"10.1111\/jcpt.12649-BIB0014|jcpt12649-cit-0014","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/hr.2017.13","article-title":"Activation of angiotensin II type 1 receptors increases D4 dopamine receptor expression in rat renal proximal tubule cells","volume":"40","author":"Tang","year":"2017","journal-title":"Hypertens Res"},{"key":"10.1111\/jcpt.12649-BIB0015|jcpt12649-cit-0015","article-title":"Validation of brain angiotensin system blockade as a novel drug target in pharmacological treatment of neuropsychiatric disorders","author":"Wincewicz","year":"2017","journal-title":"Pharmacopsychiatry"},{"key":"10.1111\/jcpt.12649-BIB0016|jcpt12649-cit-0016","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.amjhyper.2005.04.010","article-title":"Association between a dopamine-4 receptor polymorphism and blood pressure","volume":"18","author":"Sen","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1111\/jcpt.12649-BIB0017|jcpt12649-cit-0017","doi-asserted-by":"crossref","first-page":"F840","DOI":"10.1152\/ajprenal.00240.2004","article-title":"Cross talk between the intrarenal dopaminergic and cyclooxygenase-2 systems","volume":"288","author":"Zhang","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1111\/jcpt.12649-BIB0018|jcpt12649-cit-0018","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/01.HYP.0000198427.96225.36","article-title":"Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice","volume":"47","author":"Bek","year":"2005","journal-title":"Hypertension"},{"key":"10.1111\/jcpt.12649-BIB0019|jcpt12649-cit-0019","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI3685","article-title":"Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension","volume":"102","author":"Asico","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1111\/jcpt.12649-BIB0020|jcpt12649-cit-0020","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.2147\/NDT.S83989","article-title":"Rare and very rare adverse effects of clozapine","volume":"11","author":"De Fazio","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1111\/jcpt.12649-BIB0021|jcpt12649-cit-0021","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3109\/00048674.2011.616997","article-title":"Periorbital edema and treatment-resistant hypertension as rare side effects of clozapine","volume":"45","author":"Visscher","year":"2011","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1111\/jcpt.12649-BIB0022|jcpt12649-cit-0022","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4088\/JCP.v66n0905","article-title":"Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality","volume":"66","author":"Henderson","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/jcpt.12649-BIB0023|jcpt12649-cit-0023","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4088\/JCP.v65n0514","article-title":"Clozapine and hypertension: a chart review of 82 patients","volume":"65","author":"Henderson","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/jcpt.12649-BIB0024|jcpt12649-cit-0024","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/15622970801910399","article-title":"Blood pressure changes during clozapine or olanzapine treatment in Korean schizophrenic patients","volume":"10","author":"Woo","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"10.1111\/jcpt.12649-BIB0025|jcpt12649-cit-0025","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/JCP.0000000000000044","article-title":"Hypokalemic hypertension related to clozapine: a case report","volume":"34","author":"Hoorn","year":"2014","journal-title":"J Clin Psychopharmacol"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12649","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12649\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T23:07:28Z","timestamp":1750979248000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,8]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12649","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11,8]]}}}